Netflix, Q2 2025 and earnings per share
Digest more
Marsh & McLennan Companies (NYSE:MMC) posted Thursday second-quarter earnings that rose past the average analyst estimate as revenue momentum continued across its business units, along with acquisition tailwinds.
Recent portfolio additions are yielding slightly below the 7.6% core yield reported for Q2 2025, as noted by Jason Estes. Expense Outlook: Projected Q3 total expenses of $10 million, split between $1 million in oil and gas and $9 million in other expenses,
Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall biotechnology sector, as investors repositioned portfolios ahead of the release of
Anticipating a weak Tesla, Inc. Q2 and potential selloff, we highlight key updates that could boost TSLA sentiment. Click here to find out why TSLA is a Hold.
Stocks jumped to record highs on Thursday, with investors brushing off the latest Trump-Powell drama to focus on strong earnings and robust economic data.
Netflix is due to report second-quarter results after the close of trading Thursday, with Wall Street eagerly anticipating a strong kickoff to media earnings season from the giant streamer. "Currently,
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my JNJ earnings update.